TABLE 1.
The MS condition of the 9 tyrosine kinase inhibitors and IS.
| Compounds | Parent (m/z) | Product (m/z) | Fragmentor voltage (V) | Collision voltage (eV) | Retention time (min) |
|---|---|---|---|---|---|
| LEN | 427.1 | 370.1 a /312.0 | 102 | 27/43 | 2.61 |
| SOR | 465.1 | 252.1 a /270.1 | 113 | 33/24 | 3.67 |
| CBZ | 502.2 | 323.1 a /297.1 | 139 | 37/35 | 3.10 |
| RGF | 483.1 | 270.1 a /288.1 | 123 | 33/24 | 3.72 |
| APA | 398.2 | 212.1 a /184.1 | 81 | 26/37 | 3.05 |
| GEF | 447.1 | 128.1 a /100.1 | 75 | 24/47 | 2.74 |
| ANL | 408.2 | 339.1 a /304.1 | 60 | 18/40 | 2.78 |
| TIV | 370.1 | 253.1 a /158.1 | 65 | 21/22 | 3.46 |
| GAL | 370.1 | 336.1 a /325.1 | 74 | 30/29 | 1.30 |
| PRO | 260.1 | 116.13 a /183.1 | 53 | 18/18 | 3.05 |
a
Quantification ion.